SELLAS Life Sciences Group, Inc. (SLS): Nasdaq/NYSE listing notice — SELLAS receives Nasdaq deficiency notice for market value below $35M minimum

SELLAS Life Sciences Group, Inc.

Nasdaq notified SLS on Dec 6, 2023 that MV of common stock was below $35M for 30 consecutive business days.
Company has 180 calendar days, until June 3, 2024, to regain compliance under Nasdaq Listing Rule 5810(c)(3)(C).
To regain compliance, market value must be at least $35M for 10 consecutive business days during the period.
Failure to comply by June 3, 2024 may lead to delisting, subject to appeal to a Nasdaq Hearings Panel.
SLS stock remains listed on Nasdaq Capital Market under symbol SLS at this time.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

SELLAS Life Sciences Group, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2), 5810(c)(3)(C)

Exact text from the filing

December 6, 2023, SELLAS Life Sciences Group, Inc. (the “Company”) received a letter from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it no longer meets Nasdaq’s requirements for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”) because, for a period of 30 consecutive business days, the market value of the Company’s common stock, calculated based upon the most recent total shares outstanding multiplied by the closing bid price per share, has not maintained a minimum of $35.0 million. The letter does not impact the Company’s

View on SEC.gov

50 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SELLAS Life Sciences Group, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-124681

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.